ArticleThe Indian journal of medical research2025
Prevalence of impaired kidney function & its association with diabetes & hypertension in India: The ICMR-INDIAB study (ICMR-INDIAB-22).
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Long Term Exposure to Ambient Particulate MatterKidney international reports · 2026Article
- Impacting lives of people with diabetes: lessons learnt in India may be applicable to other low- and middle-income countries.Diabetologia · 2026Review
- Scale of unmet solid organ transplantation need in India: a projection for organ transplant need by 2040.The Lancet regional health. Southeast Asia · 2026Article
- Chronic kidney disease in India: Incidence, prevalence, mortality, DALYs, and State-level disparities, 1990-2023.The Indian journal of medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Chronic kidney disease remains a leading cause of morbidity and mortality in developing nations like India. This study was conducted to assess the prevalence of impaired kidney function (IKF) and its association with type 2 diabetes(T2D) and systemic hypertension (HTN) in India. Methods A total of 25,408 individuals (with/without HTN and T2D), a nationally representative sample, were included from the Indian Council of Medical Research-INdia-DIABetes (ICMR-INDIAB) cross-sectional study. IKF was defined as estimated glomerular filtration rate eGFR <60 mL/min/1.73 m2 (CKD-EPI-2009 equation-race free). Results The overall weighted prevalence of IKF was 3.2 per cent [95% confidence interval (CI): 2.9-3.5] with no significant differences between urban [3.3% (2.8-3.7)] and rural areas [3.2% (2.9-3.5)], but higher among males [3.8% (3.4-4.2)] compared to females [2.6% (2.3-2.9)]. Four States in the country had prevalence of IKF ≥6 per cent and another four States had prevalence ≥4 per cent. The decrease in eGFR for every year increase in age was around 1.0 ml/min/1.73 m2; this was greater in urban areas, females, and in those with both HTN and T2D. Presence of T2D alone was associated with significantly higher risk of IKF compared to HTN alone (Odds Ratio 3.2 vs. 2.4); however, the risk was six fold higher in individuals with both HTN and T2D. Interpretation & conclusions The burden of IKF is high across India and is likely to rise further owing to high prevalence of metabolic risk factors. T2D seems to confer higher risk of IKF compared to HTN in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.